Solanezumab, a humanized monoclonal IgG1 antibody targeting the mid-domain of the amyloid-beta (Abeta) peptide, shows promise for Alzheimers disease research [1].
Molecular Weight:
144.1 (kDa)
CAS Number:
[955085-14-0]
* VAT and and shipping costs not included. Errors and price changes excepted